CA9 and nonpapillary renal cell carcinoma: Indeed, these authors performed a comprehensive analysis of CA9 and CD147 expression patterns in resected ccRCC tumors from their patient cohort, evidencing CA9 and/or CD147 expression in 97.1% of patients while EpCAM was only detected in 18.6% of ccRCC tumors.